pathogen
rna
virus
potenti
import
group
involv
zoonot
diseas
transmiss
repres
challeng
global
diseas
control
biolog
divers
rapid
adapt
rate
prove
difficult
overcom
anticip
modern
medic
technolog
also
anthropogen
chang
natur
ecosystem
continu
popul
growth
drive
increas
rate
interspeci
contact
interchang
pathogen
develop
global
pandem
combin
molecular
epidemiolog
ecolog
knowledg
rna
virus
therefor
essenti
toward
proper
control
emerg
pathogen
review
outlin
throughout
differ
level
complex
problem
pose
rna
viral
diseas
cover
molecular
mechan
allow
adapt
new
host
speciesand
novel
pharmaceut
developmentsup
known
ecolog
process
involv
zoonot
transmiss
variabl
actual
caus
man
unintent
expos
organ
be
new
condit
life
natur
act
organ
caus
vari
charl
darwin
continu
growth
human
popul
close
link
global
trade
habitat
fragment
increasingli
promot
contact
peopl
domest
anim
wildlif
popul
contact
formerli
isol
popul
increas
risk
transmiss
parasit
expos
increas
human
interact
wild
environ
induc
number
pandem
origin
wildlif
reservoir
seen
emerg
human
immunodefici
viru
hiv
influenza
highli
pathogen
avian
influenza
nipah
hendra
sever
acut
respiratori
syndrom
coronaviru
sar
recent
ebola
viru
ebov
feldmann
jone
et
al
joseph
et
al
among
potenti
pathogen
may
involv
interspeci
transmiss
rna
virus
special
concern
particular
rna
virus
becom
import
zoonot
agent
origin
wildlif
studi
last
decad
place
rna
virus
primari
etiolog
agent
human
emerg
pathogen
occupi
emerg
infecti
diseas
rang
differ
studi
along
bacteria
overshadow
parasit
group
fungi
protozoan
helminth
binder
et
al
jone
et
al
moren
et
al
woolhous
gowtagesequeria
rna
virus
higher
probabl
infect
new
host
speci
except
shorter
gener
time
faster
evolutionari
rate
rapid
evolutionari
rate
rna
virus
build
frequent
errorpron
replic
cycl
holm
mutat
rate
rna
virus
occurroughlyat
rate
six
order
magnitud
greater
cellular
host
holm
moreov
mutabl
even
surpass
dna
virus
five
order
magnitud
eg
mutat
per
nucleotid
per
genom
replic
mngr
singlestrand
rna
phage
versu
mngr
doublestrand
dna
viru
herp
simplex
viru
type
duffi
et
al
rna
virus
often
highlight
common
class
pathogen
behind
new
human
diseas
rate
novel
virus
discov
year
rosenberg
moreov
rosenberg
suggest
small
number
novel
virus
discov
year
artifact
inadequ
surveil
tropic
subtrop
countri
even
establish
endem
pathogen
often
misdiagnos
literatur
describ
recent
emerg
interspeciestransmit
rna
virus
chikungunya
chikv
zika
zikv
virus
repres
new
global
pandem
chikv
first
well
document
asia
infect
million
tsetsarkin
et
al
recent
spread
america
weaver
forrest
follow
zikv
virus
turn
known
caus
epidem
sinc
earli
human
histori
case
avian
influenza
virus
taubenberg
moren
still
continu
produc
new
strain
current
concern
human
health
weber
et
al
wrote
use
systemat
review
five
zoonot
highli
communic
rna
virus
includ
lassa
fever
ebolaviru
middl
east
respiratori
syndrom
mer
sar
influenza
viru
iav
describ
key
inform
biolog
epidemiolog
well
provid
control
guidanc
clinic
set
type
inform
essenti
toward
proper
control
rnavir
emerg
diseas
herein
describ
problem
rnavir
diseas
repres
current
control
effort
special
attent
zoonot
rna
virus
first
section
cover
molecular
mechan
explain
rapid
adapt
rna
virus
new
select
pressur
section
cover
pharmaceut
develop
field
survey
strategi
known
yettobeknown
rnavir
diseas
next
section
show
exampl
illustr
natur
histori
relev
rna
viral
epidem
final
section
discuss
ecolog
anthropogen
factor
govern
develop
epidem
rna
virus
show
remark
capabl
adapt
new
environ
confront
differ
select
pressur
encount
select
pressur
virus
includ
host
immun
system
defens
mechan
also
current
artifici
challeng
devis
biomed
commun
ie
antivir
drug
aim
key
viral
protein
like
reversetranscriptas
inhibitor
hepat
b
c
viru
proteas
inhibitor
peculiar
rate
adapt
evolut
aris
except
high
mutat
rate
tabl
show
exampl
mutat
rate
wellstudi
rna
virus
includ
dengu
viru
denv
influenza
viru
compar
speci
microorgan
exemplifi
mutat
rate
bacteria
fungi
protozoan
virus
bacteria
rate
usual
calcul
vitro
count
chang
proport
individu
cell
viral
particl
express
certain
phenotyp
drug
resist
foster
lee
et
al
schrag
et
al
list
tabl
extens
unit
mutat
rate
alway
compar
exampl
studi
coincid
mutationspersitepergener
still
rna
virus
show
much
faster
mutat
rate
group
must
also
acknowledg
mutat
rate
vari
within
taxonom
group
exampl
domingocalap
report
rate
virus
rang
nucleotid
mutat
per
nucleotid
per
infect
cell
mnc
dna
virus
mnc
rna
virus
recollect
viral
evolutionari
rate
ie
mutat
substitut
rate
shown
virus
move
wide
rang
mutabl
singlestrand
rna
virus
one
end
doublestrand
dna
virus
duffi
gilleard
cerevisia
report
emerg
infecti
diseas
et
al
querol
et
al
domingocalap
substitut
rate
mani
emerg
rna
virus
calcul
follow
trend
shown
figur
note
rna
virus
show
greater
substitut
rate
dna
virus
spite
fact
mutat
substitut
rate
reflect
evolutionari
rate
biolog
entiti
equival
duffi
et
al
mutat
rate
raw
measur
number
genet
chang
point
mutat
insertionsdelet
accumul
time
substitut
rate
defin
number
mutat
fix
per
nucleotid
site
time
therefor
multifactori
measur
consid
mutat
rate
popul
size
gener
time
fit
profound
analysi
fundament
differ
two
evolutionari
rate
calcul
extens
comparison
dna
rna
virus
pleas
refer
duffi
et
al
singl
protein
present
rna
virus
seem
homolog
case
least
crystal
structur
obtain
today
et
al
rnadepend
polymeras
either
rnadepend
rna
polymeras
rnadepend
dna
polymeras
ie
revers
transcriptas
major
rna
viral
replicas
lack
proofread
activ
case
replic
dna
polymeras
cellular
organ
exonucleas
one
sever
protein
correct
possibl
nucleotid
misincorpor
occur
genom
replic
absenc
exonucleas
domain
fidel
polymeras
determin
steric
constraint
residu
form
activ
site
ultim
absenc
exonucleas
activ
increas
point
mutat
rate
genom
omit
error
correct
replic
process
rna
virus
correct
nucleotid
bound
activ
site
mani
favor
interact
occur
howev
incorpor
incorrect
nucleotid
make
replic
less
effici
process
number
polymerasenucleotid
interact
diminish
conform
chang
slower
deform
catalyt
site
enzym
make
phosphoryl
transfer
reaction
less
profici
castro
et
al
kunkel
error
rate
viral
rna
replicas
similar
albeit
littl
higher
cellular
dna
polymeras
latter
devoid
associ
proofread
mechan
similar
error
rate
point
toward
inher
limit
term
effici
fidel
dna
rna
polymeras
howev
prerog
surviv
seem
differ
case
dnabas
cellular
organ
huge
genom
term
length
gene
content
presenc
multipl
proofread
pathway
diminish
burden
random
mutat
henc
preserv
genet
ident
speci
nevertheless
rna
virus
found
opposit
end
benefit
mutabl
matter
fact
rna
viral
popul
consid
form
quasispeci
swarm
genet
mutant
revolv
around
consensu
sequenc
phenomenon
also
known
surviv
flattest
impli
virus
larger
number
variant
given
sequenc
ie
flatter
curv
abund
probabl
continu
replic
insid
host
holm
laur
andino
rna
viral
error
rate
limit
mutat
toler
small
increas
rate
gener
known
mutat
meltdown
error
catastroph
viral
fit
plummet
lead
viral
extinct
laur
andino
novella
et
al
principl
base
use
mutagen
agent
ribavirin
antivir
drug
interestingli
diminish
viral
mutat
rate
viral
popul
may
also
result
detriment
loss
fit
differ
experiment
condit
point
mutat
proven
alter
polymeras
fidel
higher
temperatur
lower
ph
eckert
chen
et
al
correspond
type
genom
indic
posit
neg
sens
ss
singl
strand
ds
doubl
strand
correspond
famili
also
indic
shade
area
virus
within
famili
kunkel
increas
fidel
hiv
revers
transcriptas
rt
differ
studi
mostli
picornavirida
famili
polymeras
shown
effect
point
mutat
polymeras
fidel
exampl
effect
mutat
polioviru
polymeras
pfeiffer
kirkegaard
polioviru
mutant
prove
highfidel
variant
less
pathogen
attenu
phenotyp
compar
wild
type
pfeiffer
kirkegaard
vignuzzi
et
al
similar
phenomenon
observ
mutant
chikv
bear
highfidel
polymeras
produc
less
genet
divers
caus
attenu
viral
infect
newborn
mice
mosquito
coffey
et
al
howev
studi
lowfidel
polymeras
mutant
coxacki
viru
chikv
also
demonstr
attenu
phenotyp
lower
viral
titer
et
al
rozengagnon
et
al
aforement
studi
might
conclud
viral
rnadepend
polymeras
found
point
fidel
equilibrium
slight
chang
direct
show
detriment
effect
viral
fit
differ
work
focus
unravel
potenti
proofread
function
protein
viral
cycl
coronavirus
minskaia
et
al
show
act
exoribonucleas
singlestrand
doublestrand
rna
latter
prefer
substrat
mutant
virus
lack
protein
show
defect
synthesi
subgenom
genom
viral
rna
work
murin
hepat
virusanoth
coronaviru
eckerl
et
al
show
viral
mutat
rate
higher
virus
inact
mutant
compar
wildtyp
viral
strain
later
confirm
find
use
sarscoronaviru
eckerl
et
al
smith
et
al
show
presenc
mutagen
agent
ribavirin
absenc
exonucleas
protein
significantli
increas
number
genom
mutat
also
diminish
viral
titer
within
infect
cell
demonstr
role
proofread
enzym
key
factor
coronaviru
replic
mutat
rate
calcul
sar
coronaviru
mous
hepat
viru
mutat
per
nucleotid
per
replic
cycl
mnrc
respect
sever
time
lower
correspond
exonucleasedefici
virus
mnrc
respect
eckerl
et
al
also
lower
end
rang
point
mutat
rate
calcul
rna
virus
msrc
lewi
et
al
fact
act
proofread
enzym
similar
way
exonucleas
replic
cellular
dna
polymeras
might
help
explain
uniqu
length
coronavirus
singlestrand
linear
genom
commonli
accept
tradeoff
rna
virus
genom
length
high
mutat
rate
long
rna
genom
number
mutat
accumul
replic
cycl
would
elev
inviabl
virion
would
rapidli
outnumb
viabl
one
lead
loss
fit
andor
viral
extinct
howev
roni
coronavirus
may
overcom
limit
acquir
correct
enzym
diminish
number
mutat
eckerl
et
al
propos
virus
might
switch
proofread
mechan
depend
context
allow
rapidli
adapt
new
environ
without
lose
replic
fidel
even
though
high
mutat
rate
caus
lack
proofread
mechan
main
engin
rna
viral
evolut
recombin
reassort
also
shown
play
key
role
recombin
defin
synthesi
chimer
rna
molecul
two
differ
progeni
genom
per
se
recombin
occur
singl
genom
segment
recombin
intragenom
two
segment
come
origin
infect
viru
intergenom
two
segment
come
differ
origin
differ
virus
infect
cell
case
segment
virus
packag
within
singl
virion
genom
segment
differ
progeni
virus
call
reassort
chetverin
et
al
simonlorier
holm
main
evolutionari
consequ
recombinationreassort
rna
virus
consid
increas
rate
benefici
genet
variant
obtain
effici
elimin
deleteri
mutat
simonlorier
holm
howev
differ
theori
posit
recombinationreassort
may
secondari
consequ
select
viral
characterist
physic
factor
genom
secondari
structur
may
drive
rate
phenomenon
rna
virus
et
al
presenc
evolutionari
role
recombin
reassort
demonstr
four
main
group
rna
virus
howev
estim
rate
phenomena
among
highli
variabl
viru
highest
recombin
rate
calcul
today
virion
contain
two
copi
genom
rna
strand
johnson
telesnitski
reversetranscript
process
rt
dissoci
rna
templat
sever
time
switch
anoth
rna
strand
use
templat
make
chimer
dna
strand
vitro
vivo
estim
recombin
retroviru
recombin
per
site
per
gener
cromer
et
al
schlub
et
al
shriner
et
al
recombin
major
impact
evolutionari
histori
viru
circul
recombin
form
identifi
patient
around
world
certain
adapt
trait
associ
circul
recombin
form
includ
enhanc
biolog
fit
increas
virul
pathogen
resist
antivir
vuilleumi
bonhoeff
thu
evolutionari
perspect
appear
rna
virus
benefit
larg
random
mutat
closetotheedg
mutat
rate
due
lack
proofread
mechan
result
abund
sourc
potenti
adapt
challeng
present
host
recombinationreassort
allow
emerg
new
combin
previous
exist
mutant
follow
section
medic
challeng
pose
rapid
adapt
rna
virus
discuss
effort
control
rna
viral
diseas
fight
divers
divers
diseas
difficult
high
adapt
rate
enabl
rapidli
acquir
genet
resist
tradit
control
measur
eg
vaccin
singl
drug
therapi
thu
modern
technolog
must
also
diversifi
evolv
fast
rate
control
rapidli
evolv
pathogen
agent
addit
surveil
control
divers
host
popul
reservoir
field
also
play
key
role
overal
control
measur
select
exampl
provid
modern
challeng
drug
treatment
design
attempt
overcom
fast
adapt
rate
rna
virus
also
field
control
surveil
effort
present
well
techniqu
direct
discoveri
new
virus
wild
emerg
drugresist
pathogen
one
import
medic
problem
last
decad
infecti
diseas
societi
america
spellberg
et
al
rna
virus
posit
major
concern
weber
et
al
exampl
known
hiv
acquir
signific
resist
brief
exposur
antiretrovir
drug
especi
combin
addit
drug
fact
certain
highlevel
resist
mutat
nonnucleosid
revers
transcriptas
inhibitor
occur
one
point
mutat
luca
inhibit
gener
viral
resist
multidrug
therapi
aka
highli
activ
antiretrovir
therapi
haart
emerg
viabl
strategi
soon
becam
standard
care
hivaid
patient
carpent
et
al
today
opportun
diagnost
adequ
access
varieti
drug
proper
adher
treatment
expect
life
recent
infect
person
may
similar
hivneg
popul
nakagawa
et
al
multidrug
approach
also
use
rna
virus
like
hepat
c
viru
mizokami
et
al
influenza
viru
nguyen
et
al
seo
et
al
work
mechan
multidrug
therapi
probabilist
principl
viral
particl
random
probabl
carri
one
singl
genet
resist
ie
one
singl
drug
probabl
carri
sever
combin
resist
decreas
geometr
number
drug
substanc
increas
therapeut
regimen
fact
simpl
studi
weverl
show
use
five
drug
instead
standard
threedrug
regimen
median
time
reach
rna
copiesml
week
shorter
standardthre
drugregimen
howev
simpli
increas
number
drug
substanc
practic
solut
patient
treatment
develop
sever
side
effect
long
term
adam
et
al
side
effect
antiretrovir
drug
lipodystrophi
ie
degener
fat
face
limb
upper
trunk
hyperlipidemia
insulin
resist
report
sinc
patient
receiv
potent
hiv
proteas
inhibitor
carr
et
al
studi
regard
side
effect
antivir
therapi
hepat
b
fontana
explain
nucleosid
analogu
potenti
inhibit
human
dnapolymerasegamma
involv
mitochondri
dna
replic
intracellular
mitochondri
dna
number
decreas
varieti
clinic
manifest
may
appear
neuropathi
myopathi
lactic
acidosi
exampl
nucleosid
analogu
adefovir
tenofovir
associ
proxim
renal
tubular
toxic
higher
dose
recent
report
suggest
comorbid
diabet
mellitu
dimala
et
al
also
possibl
associ
haart
therapi
secondari
effect
may
result
failur
adher
treatment
thu
despit
effect
multidrug
therapi
lack
adher
treatment
still
drive
emerg
multidrugresist
viral
strain
expos
viru
ineffect
dose
report
multidrugresist
hiv
strain
appear
sinc
earli
literatur
hiv
eg
larder
et
al
report
mutant
strain
patient
receiv
combin
therapi
zidovudin
didanosin
recent
multidrug
resist
also
report
pandem
influenza
viru
virus
sporad
appear
resist
neuraminidas
inhibitor
adamantan
memoli
et
al
studi
multiresist
hepat
viru
yim
et
al
mention
gener
multidrug
resist
facilit
sequenti
therapi
ie
drug
administ
sequenti
time
agreement
previou
observ
hiv
larder
et
al
tamura
et
al
present
revis
multidrugresist
virus
emerg
crisi
last
decad
yet
author
argu
viral
genom
mutat
indefinit
mutat
resist
must
cost
term
reduc
replic
fit
viru
hugh
andersson
boutwel
et
al
demonstr
reduc
replic
capac
hiv
viral
strain
coexpress
mutat
revers
transcriptas
host
hla
present
molecul
mutat
antiretrovir
drug
replic
fit
cost
mutat
may
explain
clinic
set
resist
strain
necessarili
frequent
koval
et
al
treatment
altern
base
principl
propos
domingo
peral
review
therapeut
approach
known
lethal
drive
viral
elimin
excess
mutat
describ
use
mutagen
nucleotid
analogu
altern
base
pair
properti
lead
induct
mutat
rivabirin
shown
mutagen
purin
analogu
polioviru
may
cure
infect
patientsinadvertentlythrough
mechan
lethal
mutagenesi
rivabirin
also
suggest
mutagen
agent
hepat
c
viru
cueva
et
al
potenti
use
lethal
mutagenesi
may
restrict
exampl
use
coronavirus
possess
proofread
enzymat
capabl
lethal
mutagenesi
approach
need
develop
especi
regard
search
nontox
mutagen
promis
viabl
antivir
strategi
interestingli
rna
virus
may
even
abl
counteract
lower
replic
fit
due
drugresist
mutat
addit
mutat
compens
loss
fit
recent
investig
report
fit
reduct
resist
mutat
hiv
proteas
rescu
mutat
vicin
viral
gag
proteolyt
cleavag
site
lead
improv
process
gag
highli
mutat
proteas
et
al
thu
addit
mutat
confer
compensatori
mechan
reduc
fit
enzym
hugh
andersson
compensatori
mutat
also
report
influenza
virus
compens
defici
viral
function
enabl
viru
acquir
na
resist
mutat
without
loss
fit
result
rapid
global
spread
hurt
extraordinari
evolutionari
capabl
rna
virus
stimul
develop
entir
divers
pharmaceut
altern
strategi
recent
strategi
also
includ
use
modern
molecular
techniqu
rna
silenc
consist
use
rna
sequenc
sirna
complementari
specif
messeng
rna
sequenc
base
pair
complementari
sequenc
drive
format
doublestrand
rna
induc
degrad
origin
messeng
rna
exampl
jacqu
et
al
direct
sirna
sever
region
genom
demonstr
reduct
viral
infect
also
use
sirna
significantli
reduc
lung
influenza
viru
titer
infect
mice
protect
lethal
challeng
tompkin
et
al
therapi
howev
earli
stage
develop
still
difficulti
chen
et
al
state
main
obstacl
use
rna
interfer
treatment
chronic
hbv
infect
lack
safe
effect
deliveri
sirna
trigger
molecul
regard
author
develop
special
deliveri
system
exampl
rozema
et
al
describ
polymerbas
system
name
dynam
polyconjug
target
deliveri
sirna
hepatocyt
modern
techniqu
vaccin
develop
also
introduc
interest
evolutionari
control
method
exampl
manipul
codon
pair
bias
coleman
et
al
basi
codon
degeneraci
genet
code
ie
exist
synonym
codon
translat
amino
acid
fact
synonym
codon
translat
less
frequent
other
coleman
collabor
develop
attenu
polioviru
strain
custom
poliovirus
contain
genet
sequenc
hundr
undertransl
synonym
codon
replic
process
genet
sequenc
within
host
cell
mice
would
therefor
less
effici
wildtyp
viru
author
report
attenu
strain
provid
protect
immun
mice
challeng
although
treatment
polioviru
influenza
hepat
c
hiv
infect
achiev
import
advanc
last
decad
specif
drug
yet
design
control
sever
remainingand
highli
pathogenicrna
virus
bray
case
confront
new
viru
one
specif
drug
yet
design
best
option
use
known
drug
substanc
rna
virus
exampl
lamivudin
nucleosideanalog
reversetranscriptas
inhibitor
use
antiretrovir
drug
hepat
b
hiv
last
ebov
outbreak
report
treatment
lamivudin
earli
infect
result
cure
patient
azango
investig
tridimension
structur
ebov
rna
polymeras
et
al
indic
certain
conserv
subdomain
architectur
protein
may
help
explain
broad
antivir
activ
certain
nucleotid
analogu
even
differ
type
rna
virus
includ
ss
ss
rna
genom
moreov
brincidofovir
antivir
activ
dna
rna
virus
conclud
specif
drug
ebov
yet
design
drug
aim
activ
site
polymeras
might
interfer
function
ebov
rna
polymeras
albeit
less
specif
consider
highlight
import
phylogenet
studi
newli
discov
virus
studi
may
help
direct
emerg
therapeut
action
design
specif
antivir
drug
interestingli
although
common
ancestri
ebov
retrovirus
yet
clear
known
l
protein
ebov
homolog
revers
transcriptas
et
al
protein
activ
site
ie
palm
subdomain
highli
conserv
ergo
inhibit
effect
drug
expect
protein
regard
develop
heterolog
vaccin
within
filovirus
also
explor
warfield
et
al
demonstr
protect
efficaci
use
ebov
viruslik
particl
forest
viru
within
ebolaviru
genu
although
univers
drug
rna
virus
possibl
certain
substanc
similar
virus
may
serv
purpos
preliminari
control
emerg
situat
unfortun
rel
phylogenet
close
alway
use
aid
vaccin
develop
exampl
despit
pathogenesi
sar
well
character
much
knowledg
applic
mer
viru
maslow
known
sar
infect
cell
bind
enzym
wide
express
mammal
ie
angiotensin
convert
enzym
wong
et
al
murin
mammalian
anim
readili
use
model
test
candid
vaccin
sar
hand
howev
mer
viru
bind
cell
surfac
dipeptidylpeptidas
receptor
bind
domain
differ
suscept
nonsuscept
speci
li
et
al
mer
restrict
primat
camelid
bat
reason
rodent
use
model
wherea
camel
alpaca
primat
develop
infect
crameri
et
al
expens
model
vaccin
test
kind
difficulti
delay
develop
vaccin
emerg
diseas
also
lack
data
immunogen
dose
safeti
hinder
progress
et
al
faster
vaccin
develop
must
prioriti
respond
outbreak
emerg
ebov
outbreak
africa
also
boost
chang
classic
paradigm
vaccin
develop
emerg
infecti
diseas
alter
includ
exampl
advanc
studi
phase
iiiii
phase
still
complet
also
novel
clinic
trial
design
emerg
particular
ring
vaccin
strategi
maslow
strategi
use
stage
approach
direct
contact
patient
infect
ebov
group
ring
ring
random
earli
immedi
versu
late
delay
day
inocul
design
use
test
efficaci
rvsvvector
vaccin
express
ebola
surfac
glycoprotein
henaorestrepo
et
al
report
case
ebov
diseas
immedi
vaccin
group
peopl
case
found
delay
vaccin
group
peopl
accord
maslow
vaccin
emerg
infecti
diseas
ebov
mer
zikv
repres
uniqu
paradigm
standard
vaccin
develop
principl
addit
effort
control
prevent
viral
diseas
extend
laboratori
clinic
wildlif
surveil
follow
section
exampl
given
modern
field
survey
techniqu
strategi
monitor
potenti
viral
threat
sinc
nearli
viral
diseas
infect
human
zoonot
mors
et
al
field
survey
rna
virus
must
conduct
monitor
domest
andor
wildlif
reservoir
popul
tabl
show
exampl
zoonot
rna
virus
known
suspect
reservoir
rout
zoonot
transmiss
reservoir
understood
speci
taxonom
group
pathogen
perman
maintain
infect
may
transmit
anoth
speci
definit
modifi
haydon
et
al
know
ecolog
reservoir
speci
main
rout
interspeci
transmiss
central
prevent
campaign
particular
larg
dens
reservoir
popul
may
predict
larg
pathogen
load
virul
anderson
et
al
certain
speci
bat
calish
et
al
bird
speci
cui
et
al
increasingli
recogn
major
reservoir
sever
virus
remark
report
bat
serv
reservoir
host
greater
viral
divers
host
speci
exampl
rodent
lui
et
al
oshea
et
al
reservoir
capabl
bat
may
aris
firstli
roost
behavior
larg
dens
congreg
greatli
promot
transmiss
secondli
fli
capabl
ampl
home
rang
potenti
allow
transloc
viral
strain
across
larg
geograph
region
drexler
et
al
suggest
predomin
host
switch
bat
mammal
bird
fact
place
bat
tent
ancestr
host
major
paramyxovirida
subfamili
paramyxovirina
pneumovirina
paramyxovirida
speci
respons
signific
human
domest
anim
viral
diseas
measl
distemp
mump
parainfluenza
newcastl
diseas
relev
anim
speci
transmiss
cycl
viral
diseas
includ
vector
mosquito
aed
aegypti
albopictu
spread
denv
chikv
zikv
yellow
fever
viru
yfv
barbazan
et
al
lenhart
et
al
effort
monitor
speci
also
includ
use
modern
remot
sens
technolog
use
satellit
imageri
climat
data
predict
potenti
distribut
quattrochi
et
al
field
surveil
strategi
must
also
incorpor
molecular
techniqu
allow
identif
novel
virus
instead
monitor
wellknown
viral
speci
modern
sequenc
techniqu
eg
shotgun
sequenc
allow
discoveri
novel
plant
anim
virus
al
rwahnih
et
al
exampl
work
drexler
et
al
sampl
bat
rodent
speci
allow
identif
new
paramyxovirus
li
et
al
propos
interest
field
survey
strategi
involv
sequenc
viral
genom
contain
bat
guano
result
total
sequenc
read
bat
guano
california
texa
allow
identifi
virus
infect
insect
reflect
diet
insectivor
bat
plant
fungi
possibl
reflect
diet
ingest
insect
also
viral
sequenc
infect
mammal
latter
includ
famili
parvovirida
circovirida
picornavirida
adenovirida
poxvirida
astrovirida
coronavirida
henc
peculiar
habit
wildlif
popul
use
studi
virus
carri
transmit
may
also
use
assess
viral
biodivers
ecosystem
howev
modern
sequenc
techniqu
econom
restrict
certain
develop
countri
unfortun
suscept
environ
infecti
diseas
tropic
also
coincid
signific
econom
limit
local
health
author
thu
essenti
find
altern
effect
econom
access
interest
exampl
found
work
villing
et
al
lowcost
techniqu
use
ie
high
resolut
melt
rtpcr
techniqu
evalu
viral
divers
dissoci
curv
dna
versu
temperatur
instead
use
costli
sequenc
techniqu
also
identifi
potenti
new
virus
use
degener
primer
specif
design
preferenti
target
rna
viral
genom
host
rna
villing
et
al
report
result
compar
gold
standard
describ
presenc
clade
hemorrhag
fever
arbovirus
previous
isol
kenia
lowcost
strategi
may
repres
feasibl
approach
lowbudget
scenario
frequent
found
region
expos
infecti
pathogen
field
surveil
wildlif
popul
access
molecular
techniqu
may
help
reveal
viral
threat
still
determin
emerg
reemerg
space
time
difficult
predict
model
great
potenti
prevent
control
strategi
eisen
eisen
fischer
et
al
gao
et
al
wu
cowl
particular
remot
sens
environment
factor
allow
predict
vector
reservoir
abund
larg
continu
geograph
region
exampl
combin
remot
sens
environment
data
point
data
mosquito
abund
light
trap
collect
diukwass
et
al
develop
logist
model
low
high
abund
mosquito
vector
west
nile
viru
connecticut
unit
state
model
predict
high
abund
culex
pipien
nonforest
area
surfac
water
distanc
estuari
predict
high
abund
c
salinariu
also
surfac
water
grasslandsagricultur
predict
aed
vexan
final
season
differ
normal
differ
veget
index
distanc
palustrin
habitat
predict
culiseta
melanura
interest
model
peterson
et
al
suggest
spread
pattern
west
nile
viru
best
explain
includ
migratori
bird
critic
longdist
transport
agent
mathemat
model
assess
exampl
popul
effect
vaccin
domest
anim
prevent
develop
zoonot
diseas
reynold
et
al
found
influenza
outbreak
swine
breed
herd
model
predict
persist
high
level
infecti
piglet
robust
even
chang
transmiss
rate
farm
size
model
also
predict
vaccin
elimin
influenza
outbreak
gener
monitor
predict
control
rna
viral
diseas
proven
difficult
task
everi
effort
crucial
design
novel
drug
therapi
discoveri
potenti
new
threat
wild
addit
ecolog
knowledg
zoonot
outbreak
develop
also
fundament
prevent
control
rna
viral
diseas
known
exampl
interspeci
pandem
strongli
relat
global
land
use
chang
invas
natur
ecosystem
growth
dens
human
settlementsa
well
growth
global
trade
mobilityar
drive
increas
rate
interspeci
contact
interchang
parasit
pathogen
develop
global
pandem
phenomena
compris
intric
network
sever
actor
wildlif
speci
domest
anim
global
interact
human
popul
section
review
exampl
illustr
natur
histori
zoonot
outbreak
rna
virus
major
influenza
epidem
appar
occur
sinc
least
middl
age
taubenberg
moren
wellregist
pandem
sinc
sever
outbreak
influenza
viral
strain
north
america
spread
highli
pathogen
avian
influenza
virus
report
zoonot
infect
detect
china
also
present
ongo
infect
middl
east
zoonot
infect
continu
occur
joseph
et
al
well
known
wild
aquat
bird
natur
reservoir
iav
subtyp
joseph
et
al
also
subtyp
found
bat
speci
tong
et
al
viral
strain
usual
circul
endem
within
natur
reservoir
ie
enzoot
howev
continu
interspeci
contact
may
facilit
spillov
viral
strain
toward
speci
ie
epizoot
event
therefor
addit
wildlif
reservoir
influenza
virus
infect
rang
host
speci
includ
domest
anim
human
webster
et
al
colon
new
host
speci
may
requir
viral
diversif
strategi
escap
host
immun
system
iav
abil
gene
recombin
rapid
genet
antigen
evolut
enabl
readili
adapt
new
immunogen
environ
also
make
vaccin
effort
difficult
human
domest
anim
webster
et
al
wild
migratori
waterfowl
waterbird
sourc
viral
subtyp
antigen
novel
human
obenau
et
al
known
introduct
influenza
strain
novel
subtyp
human
circul
caus
pandem
due
antigen
shift
taubenberg
moren
antigen
shift
refer
phenotyp
chang
viral
surfac
antigen
due
genet
recombin
novel
combin
differ
enough
origin
strain
avoid
immun
memori
previous
expos
individu
influenza
strain
found
domest
anim
pig
kida
et
al
dog
song
et
al
usual
repres
signific
threat
human
health
domest
anim
act
intermedi
host
reassort
avian
human
virus
occur
fact
molecular
analys
show
iav
strain
subtyp
found
human
close
relat
swine
iav
strain
joseph
et
al
interestingli
ferret
also
identifi
host
recent
emerg
strain
zhu
et
al
although
direct
transmiss
iav
wild
bird
human
may
rare
least
one
laboratoryconfirm
report
contract
interact
dead
wild
swan
azerbaijan
gilsdorf
et
al
also
serolog
evid
exposur
also
found
alaskan
hunter
interact
dead
wild
avian
specimen
reed
et
al
recent
detect
avian
viru
wildlif
popul
rais
concern
potenti
reemerg
pandem
watanab
et
al
joseph
et
al
emphas
increas
human
intrus
wildlif
habitat
increas
risk
emerg
reemerg
iav
strain
mosquitoborn
chikv
first
discov
present
day
tanzania
outbreak
sinc
spread
africa
asia
europ
south
pacif
andmost
recentlyto
america
weaver
forrest
enzoot
transmiss
cycl
chikv
subsaharan
africa
consist
forestdwel
mosquito
vector
nonhuman
primat
host
speci
ie
sylvat
cycl
althous
et
al
tsetsarkin
et
al
weaver
forrest
urban
chikv
cycl
affect
human
presum
origin
peopl
live
near
african
forest
becam
infect
bite
wildlif
mosquito
speci
aed
furcif
furcif
mosquito
may
occasion
occupi
urban
nich
within
villag
settl
vicin
forest
diallo
et
al
howev
differ
mosquito
speci
aed
aegyptii
better
adapt
artifici
water
contain
oviposit
site
human
blood
sourc
nutrient
becam
global
widespread
human
migrat
powel
tabachnick
similarli
although
recent
mosquito
albopictu
histori
global
expans
facilit
human
migrat
trade
matter
fact
introduct
albopictu
unit
state
report
sinc
reiter
sprenger
intercontinent
shipment
use
tire
least
partial
respons
chikv
epidem
appar
aros
peopl
infect
spillov
event
enzoot
chikv
reach
locat
popul
domest
mosquito
contact
peopl
adequ
initi
interhuman
transmiss
ie
urban
transmiss
cycl
tsetsarkin
et
al
weaver
enlist
prevent
strategi
arthropodborn
virus
author
indic
arthropodborn
rna
virus
denv
yfv
chikv
presum
spill
sylvat
cycl
infect
peopl
live
vicin
natur
area
may
ultim
transport
viru
urban
cycl
thu
viabl
prevent
strategi
spillov
event
reduc
exposur
human
popul
sylvat
vector
andor
reduc
suscept
vaccin
simpl
solut
reduc
exposur
includ
use
bed
net
offer
protect
mosquito
bite
turn
prospect
develop
vaccin
chikv
fact
promis
due
limit
antigen
variat
viru
weaver
et
al
vaccin
campaign
preferenti
target
peopl
closer
contact
sylvat
cycl
weaver
et
al
stress
import
priorit
develop
vaccin
vectorborn
virus
sar
coronaviru
spread
countri
contin
leav
death
estim
cost
billion
china
tourism
profit
greatorex
et
al
literatur
suggest
increas
intern
wildlif
trade
countri
china
vietnam
lao
peopl
democrat
republ
may
play
import
role
sar
outbreak
bell
et
al
greatorex
et
al
accord
greatorex
collabor
wildlif
meat
exist
dietari
compon
lao
mani
gener
practic
remain
limit
local
subsist
consumpt
howev
econom
open
countri
earli
wildlif
trade
gain
momentum
establish
onset
develop
epidem
observ
studi
market
lao
greatorex
et
al
identifi
four
relev
risk
factor
zoonot
transmiss
wildlif
diseas
wildlifehuman
contact
highvolum
market
author
found
averag
daili
count
aliv
fresh
dead
anim
rang
anim
per
day
handl
market
trade
anim
potenti
carri
zoonot
diseas
author
observ
trade
famili
mammal
murida
rat
speci
suida
wild
pig
pteropodida
fruit
bat
sciurida
tree
fli
squirrel
cervida
muntjac
sambar
leporida
hare
felida
leopard
cat
rhinolophida
insectivor
bat
viverida
civet
herpestida
mongoos
hystricida
porcupin
lorisida
lori
capabl
host
signific
zoonos
includ
rabi
sar
leptospirosi
mycobacterium
tuberculosi
complex
poor
biosafeti
market
personnel
show
riski
behavior
food
contamin
lack
hand
wash
clean
tabl
practic
sell
wildlif
alongsid
fresh
product
poor
market
cleanli
gener
factor
repres
risk
direct
human
infect
potenti
human
spread
diseas
market
wider
popul
studi
major
highvolum
market
locat
within
larg
town
main
road
facilit
contact
larg
human
settlement
also
abl
observ
foreign
visitor
licens
plate
countri
market
suggest
potenti
intern
spread
activ
wildlif
market
therefor
potenti
factor
onset
zoonot
outbreak
abovement
characterist
must
assess
studi
develop
epidem
direct
effort
prevent
also
accord
bell
et
al
major
lesson
sar
outbreak
newli
emerg
zoonot
diseas
occur
parallel
biodivers
crise
wildlif
overexploit
increas
human
activ
commerci
demand
accord
holm
evolutionari
ecolog
gener
may
allow
largescal
predict
interspecif
transmiss
wellestablish
rule
pathogen
like
jump
phylogenet
relat
host
exampl
streicker
et
al
demonstr
frequenc
interspeci
transmiss
rabi
viru
decreas
increas
phylogenet
distanc
bat
host
speci
yet
phylogenet
barrier
appear
less
signific
virus
pathogen
davi
pedersen
studi
differ
pathogen
commun
protozoan
helminth
virus
primat
human
observ
thatfor
viruseshost
phylogenet
distanc
less
import
geographi
explain
pathogen
commun
similar
host
suggest
geograph
overlap
neighbor
host
relev
due
rapid
evolut
viral
lineag
allow
jump
host
across
larger
evolutionari
distanc
moreov
holm
highlight
rna
virus
jump
speci
boundari
often
dna
virus
like
aris
differ
rate
evolutionari
chang
ecolog
rule
explain
pattern
process
viral
emerg
like
instanc
viral
emerg
root
ecolog
perturb
case
quantit
model
account
local
human
disturb
undoubtedli
help
predict
futur
interspeci
transmiss
event
exampl
land
use
gradient
may
modifi
dispers
genet
evolut
virus
zirkel
et
al
zirkel
et
al
show
gradient
tropic
rainforest
agricultur
land
use
genet
divers
newli
discov
nidoviru
caval
viru
decreas
preval
increas
mosquito
popul
along
process
spread
disturb
habitat
studi
ranavirus
doublestrand
dna
virus
price
et
al
reveal
signific
trend
elev
rate
outbreak
local
higher
human
popul
densiti
pattern
like
explain
anthropogen
transloc
virus
countri
stimul
spread
novel
viral
strain
dens
popul
area
price
et
al
hand
propos
diseas
risk
interspeci
transmiss
lower
ecosystem
trophic
chain
remain
conserv
ostfeld
holt
interspeci
transmiss
alon
howev
factor
consid
potenti
pandem
major
epizoot
event
result
deadend
spillov
infect
ie
viru
establish
onward
transmiss
human
popul
yet
pandem
exampl
ebov
gire
et
al
sar
hiv
ostfeld
holt
capabl
establish
transmiss
network
among
human
host
except
common
zoonot
pattern
human
acquir
infect
anim
reservoir
geoghegan
et
al
present
interest
analysi
virolog
featur
may
predict
adequaci
human
emerg
author
use
multivari
approach
assess
best
predictor
humantohuman
transmiss
determin
virus
induc
low
host
mortal
establish
longterm
chronic
infect
nonseg
nonenvelop
transmit
vector
like
transmiss
human
regard
low
transmiss
vectorborn
virus
coffey
et
al
explain
interspeci
transfer
arbovirus
may
constrain
altern
infect
dissimilar
host
optim
reproduct
one
host
may
involv
fit
tradeoff
addit
multivari
studi
geoghegan
et
al
found
genom
variabl
lower
predict
power
aforesaid
virolog
featur
fact
holm
suggest
previous
viral
genet
studi
would
inform
possibl
associ
genet
inform
specif
phenotyp
viru
identifi
abil
chang
host
speci
success
establish
transmiss
within
human
popul
therefor
special
concern
recent
evid
publish
sexual
transmiss
zikv
dortenzio
et
al
musso
et
al
pose
major
public
health
emerg
around
globe
mathemat
model
gao
et
al
suggest
sexual
transmiss
zikv
increas
risk
infect
size
epidem
well
prolong
outbreak
regard
risk
humantohuman
transmiss
woolhous
et
al
classifi
virus
four
level
accord
basic
reproduct
number
rate
transmiss
human
r
defin
averag
number
secondari
case
gener
singl
primari
case
level
virus
would
without
current
abil
infect
human
present
wildlif
popul
may
eventu
jump
human
observ
sar
ebov
merscov
special
concern
found
primat
speci
also
bat
bird
r
undefin
primari
case
inexist
level
virus
infect
human
spread
human
popul
eg
rabi
viru
r
yet
virus
may
eventu
acquir
genet
abil
spread
amongst
human
hypothes
lineag
emerg
strain
simian
immunodefici
virus
capabl
overcom
key
host
restrict
ie
human
tetherin
sharp
hahn
level
virus
may
occasion
transmit
human
r
exampl
novel
rhabdoviru
bascongo
viru
shown
transmiss
human
woolhous
et
al
final
level
virus
spread
epidem
amongst
human
r
interestingli
arbovir
level
virus
zikv
chikv
yfv
denv
indic
highlevel
spread
human
popul
link
carriag
anthropophil
vector
gener
risk
assess
potenti
zoonot
viral
threat
requir
combin
genet
phenotyp
epidemiolog
inform
virus
along
ecolog
reservoirsvector
expans
human
activ
affect
natur
ecosystem
yet
instead
concern
intercontinent
threat
author
point
insid
local
mayaro
viru
mayv
mayv
arboviru
sylvat
transmiss
cycl
similar
yfv
chikv
moreov
per
author
symptom
mayv
infect
overlap
easili
confus
chikv
zikv
denv
pose
signific
diagnost
challeng
novel
threat
next
potenti
emerg
pathogen
america
asia
new
emerg
virus
also
describ
banna
viru
show
rapid
evolutionari
rate
potenti
introduc
nonendem
area
liu
et
al
hand
longknown
viral
diseas
overlook
still
repres
threat
despit
medic
effort
even
though
million
vaccin
dose
yfv
distribut
past
year
decemb
yfv
outbreak
identifi
angola
may
total
suspect
case
report
includ
death
thu
committe
conven
world
health
organ
may
decid
current
epidem
seriou
public
health
concern
barrett
moreov
accord
barrett
nearli
million
yfv
dose
reserv
emerg
howev
reserv
may
suffici
meet
demand
larg
outbreak
especi
area
yfv
gone
decad
without
urban
outbreak
case
angola
current
plan
action
may
research
develop
blueprint
includ
viral
diseas
urgent
address
necessit
action
soon
possibl
ie
crimean
congo
hemorrhag
fever
viru
ebov
marburg
viru
sarscov
merscov
lassa
fever
viru
nipah
viru
rift
valley
fever
viru
chikv
et
al
constant
monitor
rna
viral
diseas
prevent
pharmaceut
product
therefor
crucial
time
detect
intervent
avoid
sever
outbreak
futur
regard
work
hotez
stress
need
econom
polit
innov
run
parallel
scientif
effort
emerg
neglect
diseas
hotez
propos
combin
global
fund
coalit
epidem
prepared
innov
alongsid
nation
fund
wealthi
countri
nation
paradox
accord
hotez
work
account
world
povertyrel
ill
order
secur
suffici
fund
time
develop
adequ
monitor
pharmaceut
respons
final
control
certain
rna
viral
diseas
also
problemat
social
reason
exampl
global
control
hiv
current
expect
result
reach
vulner
commun
reportedli
challeng
due
social
stigma
hivinfect
peopl
certain
circumst
hivposit
patient
may
reject
treatment
fear
seen
local
clinic
gilbert
walker
target
discrimin
healthcar
provid
chan
et
al
katz
et
al
stringer
et
al
despit
expans
access
drug
therapi
addit
global
econom
crise
driven
gener
budget
cut
hiv
control
effort
difficulti
potenti
explain
alarm
deceler
annual
declin
new
hiv
infect
past
year
countri
includ
egypt
mexico
russia
philippin
slightli
increas
rate
new
infect
steel
unfortun
diseas
control
ultim
limit
econom
social
constraint
thu
design
pharmaceut
substanc
survey
techniqu
must
also
cope
feasibl
implement
popul
level
involv
complex
network
educ
polici
decis
maker
must
acknowledg
human
activ
natur
ecosystem
also
current
budget
polici
social
knowledgeat
local
global
levelsthat
determin
progress
epidem
pathogen
rna
virus
one
import
group
pathogen
involv
zoonot
transmiss
event
challeng
global
diseas
control
unknown
viral
speci
wild
also
known
decadesor
even
centuriesstil
repres
continu
problem
human
anim
health
biolog
divers
rapid
adapt
rate
proven
difficult
overcom
stimul
continu
develop
pharmaceut
medic
technolog
technolog
develop
specif
design
survey
control
rna
virus
must
therefor
research
prioriti
addit
continu
monitor
viral
genet
phenotyp
wildlif
reservoir
also
crucial
reservoir
may
constant
sourc
novel
pathogen
materi
human
human
activ
polici
possibl
best
predictor
extent
sever
futur
epidem
perhap
best
strategi
rna
viral
diseas
design
prevent
survey
program
evalu
vulner
sector
geograph
region
program
aid
develop
plan
guarante
exist
suffici
adequ
access
treatment
final
conserv
polici
control
disturb
natur
ecosystem
also
essenti
